Pharmaceuticals | Free Full-Text | A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza) | HTML
Azacitidine | Nature Reviews Drug Discovery
Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network | Leukemia
Myelodysplastic Syndromes: Tailoring Treatment to Optimize Patient Outcomes This program is supported by an educational donation from. - ppt download
Spotlight on decitabine for myelodysplastic syndromes in Chinese patie | OTT
Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action | SpringerLink
Intracellular methabolic pathways of azacitidine and decitabine. After... | Download Scientific Diagram
Hypomethylating agents are effective in myelodysplastic syndrome | Cancer Biology
Decitabine—Bedside to bench - ScienceDirect
JCI - Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes
Decitabine (Dacogen) - Oncology Nurse Advisor
Clinical update on hypomethylating agents | SpringerLink
Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors | Epigenomics
Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia
Nucleosidic DNA demethylating epigenetic drugs – A comprehensive review from discovery to clinic - ScienceDirect
Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers | Clinical Epigenetics | Full Text
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine - Stresemann - 2008 - International Journal of Cancer - Wiley Online Library
Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemia
Azacitidine - Wikipedia
JCI - Clinical development of demethylating agents in hematology
Synergistic Effect of Epigenetic Inhibitors Decitabine and Suberoylanilide Hydroxamic Acid on Colorectal Cancer In vitro | Bentham Science
Figure 2 from Targeting DNA Methylation | Semantic Scholar
PDF) An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes
